Figure 3

Individual and geometric mean single-dose plasma roniciclib concentration–time profiles on day 1. SCLC expansion cohort is shown in (A) and ovarian cancer expansion cohort (5 mg BID and 5/10 mg BID) is shown in (B).
Individual and geometric mean single-dose plasma roniciclib concentration–time profiles on day 1. SCLC expansion cohort is shown in (A) and ovarian cancer expansion cohort (5 mg BID and 5/10 mg BID) is shown in (B).